Regenxbio Inc

NASDAQ:RGNX  
48.27
-1.68 (-3.36%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.95B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$28.77 Million
Adjusted EPS-$1.05
See more estimates
10-Day MA$47.99
50-Day MA$41.01
200-Day MA$35.69
See more pivots

REGENXBIO Inc. Stock, NASDAQ:RGNX

9600 BLACKWELL ROAD, SUITE 210, ROCKVILLE, MD 20850
United States of America
Phone: 240-552-8181
Number of Employees: 192

Description

Developing gene therapies for rare diseases with a proprietary delivery platform.